Patients should avoid engaging in any high-risk activities (e.g., driving, exercise, etc.) within 2 to 3 hours after dosing, particularly during the initiation of INCRELEX treatment until tolerability and a stable dose have been established [see Adverse Reactions (6.1)]
The products were obtained by silica gel column chromatography
of these, 3 patients had 2 immune-related adverse events
Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market
Administration of a solo injection of MTX induced an 11.44-fold elevation in collagen deposition compared with the control group